Symbicort Rapihaler Therapeutic Equivalence Study

PHASE3CompletedINTERVENTIONAL
Enrollment

742

Participants

Timeline

Start Date

September 30, 2007

Primary Completion Date

April 30, 2008

Study Completion Date

April 30, 2008

Conditions
Bronchial Asthma
Interventions
DRUG

Symbicort Turbuhaler

Symbicort Turbuhaler® 80/4.5 μg 1 Inhalation Twice Daily

DRUG

Symbicort pMDI

Symbicort®pMDI® 40/2.25 μg 2 Actuations Twice Daily

DRUG

Pulmicort Turbuhaler

Pulmicort®Turbuhaler® 100 μg 1 Inhalation Twice Daily

Trial Locations (48)

Unknown

Research Site, Pleven

Research Site, Plovdiv

Research Site, Rousse

Research Site, Sofia

Research Site, Varna

Research Site, Benesov U Prahy

Research Site, Hradec Králové

Research Site, Jihlava

Research Site, Kladno

Research Site, Kolín

Research Site, Kutná Hora

Research Site, Litoměřice

Research Site, Neratovice

Research Site, Pardubice

Research Site, Prague

Research Site, Rokycany

Research Site, Strakonice

Research Site, Balassagyarmat

Research Site, Budapest

Research Site, Cegléd

Research Site, Debrecen

Research Site, Deszk

Research Site, Győr

Research Site, Gyula

Research Site, Kaposvár

Research Site, Nyíregyháza

Research Site, Szarvas

Research Site, Százhalombatta

Research Site, Szeged

Research Site, Törökbálint

Research Site, Bialystok

Research Site, Bielsko-Biala

Research Site, Bydgoszcz

Research Site, Chodzież

Research Site, Chrzanów

Research Site, Karpacz

Research Site, Krakow

Research Site, Lodz

Research Site, Lublin

Research Site, Ostrów Wielkopolski

Research Site, Poznan

Research Site, Skierniewice

Research Site, Szczecin

Research Site, Tarnów

Research Site, Turek

Research Site, Wodzisław Śląski

Research Site, Wroclaw

Research Site, Łomża

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY